Neuroimaging of individuals with Down's syndrome at-risk for dementia: Evidence for possible compensatory events

NeuroImage

Volumn 39, Issue 3, 2008, Pages 1324-1332

  Haier, R J ^a,b   Head, K ^a   Head, E ^b   Lott, I T ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Brain imaging; Dementia; Down's syndrome; MRI; PET; Pre clinical AD; Voxel based morphometry

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; CAREGIVER; CAUDATE NUCLEUS; CLINICAL ARTICLE; CORRELATION ANALYSIS; DEMENTIA; DOWN SYNDROME; FEMALE; FRONTAL LOBE; GLUCOSE METABOLISM; GRAY MATTER; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; INTELLIGENCE; MALE; MORPHOMETRICS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STRUCTURED INTERVIEW; SYMPTOM; THALAMUS;

ADULT; BRAIN CHEMISTRY; COGNITION; DATA INTERPRETATION, STATISTICAL; DEMENTIA; DOWN SYNDROME; EMOTIONS; FEMALE; FOLLOW-UP STUDIES; GLUCOSE; HUMANS; INDIVIDUALITY; KINETICS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; RISK;

EID: 37849004936     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2007.09.064     Document Type: Article

References (73)

1. Alexander G.E., Chen K., Pietrini P., Rapoport S.I., and Reiman E.M. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. Am. J. Psychiatry 159 5 (2002) 738-745
2. Ashburner J., and Friston K.J. Voxel-based morphometry-The methods. NeuroImage 11 6 Pt 1 (2000) 805-821
3. Ashburner J., and Friston K.J. Why voxel-based morphometry should be used. NeuroImage 14 6 (2001) 1238-1243
4. Aylward E.H., Burt D.B., Thorpe L.U., Lai F., and Dalton A. Diagnosis of dementia in individuals with intellectual disability. J. Intellect. Disabil. Res. 41 Pt 2 (1997) 152-164
5. Aylward E.H., Li Q., Honeycutt N.A., Warren A.C., Pulsifer M.B., Barta P.E., Chan M.D., Smith P.D., Jerram M., and Pearlson G.D. MRI volumes of the hippocampus and amygdala in adults with Down's syndrome with and without dementia. Am. J. Psychiatry 156 4 (1999) 564-568
6. Bokde A.L.W., Teipel S.J., Drzezga A., Thissen J., Bartenstein P., Dong W., Leinsinger G., Born C., Schwaiger M., Moeller H.J., and Hampel H. Association between Cognitive Performance and Cortical Glucose Metabolism in Patients with Mild Alzheimer's Disease. Dementia Geriatr. Cognit. Disord. 20 6 (2005) 352
7. Bondi M.W., Houston W.S., Eyler L.T., and Brown G.G. fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology 64 3 (2005) 501-508
8. Bookheimer S.Y., Strojwas M.H., Cohen M.S., Saunders A.M., Pericak-Vance M.A., Mazziotta J.C., and Small G.W. Patterns of brain activation in people at risk for Alzheimer's disease. N. Engl. J. Med. 343 7 (2000) 450-456
9. Braak H., and Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 18 4 (1997) 351-357
10. Coppus A., Evenhuis H., Verberne G.J., Visser F., van Gool P., Eikelenboom P., and van Duijin C. Dementia and mortality in persons with Down's syndrome. J. Intellect. Disabil. Res. 50 10 (2006) 768-777
11. Csernansky J.G., Wang L., Swank J., Miller J.P., Gado M., McKeel D., Miller M.I., and Morris J.C. Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly. NeuroImage 25 3 (2005) 783
12. Dani A., Pietrini P., Furey M.L., McIntosh A.R., Grady C.L., Horwitz B., Freo U., Alexander G.E., and Schapiro M.B. Brain cognition and metabolism in Down syndrome adults in association with development of dementia. NeuroReport 7 18 (1996) 2933-2936
13. de Leon M.J., Convit A., Wolf O.T., Tarshish C.Y., DeSanti S., Rusinek H., Tsui W., Kandil E., Scherer A.J., Roche A., Imossi A., Thorn E., Bobinski M., Caraos C., Lesbre P., Schlyer D., Poirier J., Reisberg B., Fowler J., de Asis J., De Santi S., Wegiel J., Saint Louis L.A., Wisniewski H.M., Tarnawski M., Miller D.C., Reiman E.M., Uecker A., Caselli R.J., Lewis S., Bandy D., Osborne D., Weaver A., Thibodeau S.N., George A.E., Carroll R., Tarshish C., George A., Golomb J., Kluger A., McRae T., Ferris S.H., Ince C., Quinn B., Miller D., and Wisniewski H. Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy- d-glucose/positron-emission tomography (FDG/PET). Proc. Natl. Acad. Sci. U. S. A. 98 19 (2001) 10966-10971
14. Deb S., and Braganza J. Comparison of rating scales for the diagnosis of dementia in adults with Down's syndrome. J. Intellect. Disabil. Res. 43 Pt 5 (1999) 400-407
15. Deb S., de Silva P.N., Gemmell H.G., Besson J.A., Smith F.W., and Ebmeier K.P. Alzheimer's disease in adults with Down's syndrome: the relationship between regional cerebral blood flow equivalents and dementia. Acta Psychiatr. Scand. 86 5 (1992) 340-345
16. Dekosky S.T., and Scheff S.W. Synapse Loss In Frontal-Cortex Biopsies In Alzheimers-Disease-Correlation With Cognitive Severity. Ann. Neurol. 27 5 (1990) 457-464
17. DeKosky S.T., Ikonomovic M.D., Styren S.D., Beckett L., Wisniewski S., Bennett D.A., Cochran E.J., Kordower J.H., and Mufson E.J. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann. Neurol. 51 2 (2002) 145-155
18. den Heijer T., Geerlings M.I., Hoebeek F.E., Hofman A., Koudstaal P.J., and Breteler M.M.B. Use of Hippocampal and Amygdalar Volumes on Magnetic Resonance Imaging to Predict Dementia in Cognitively Intact Elderly People. Arch. Gen. Psychiatry 63 1 (2006) 57-62
19. Dickerson B.C., Salat D.H., Bates J.F., Atiya M., Killiany R.J., Greve D.N., Dale A.M., Stern C.E., Blacker D., Albert M.S., and Sperling R.A. Medial temporal lobe function and structure in mild cognitive impairment. Ann. Neurol. 56 1 (2004) 27-35
20. Dickerson B.C., Salat D.H., Greve D.N., Chua E.F., Rand-Giovannetti E., Rentz D.M., Bertram L., Mullin K., Tanzi R.E., Blacker D., Albert M.S., and Sperling R.A. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology 65 3 (2005) 404-411
21. Evenhuis H.M. Evaluation of a screening instrument for dementia in ageing mentally retarded persons. J. Intellect. Disabil. Res. 36 Pt 4 (1992) 337-347
22. Evenhuis H.M. Further evaluation of the Dementia Questionnaire for Persons with Mental Retardation (DMR). J. Intellect. Disabil. Res. 40 Pt 4 (1996) 369-373
23. Fleisher A.S., Houston W.S., Eyler L.T., Frye S., Jenkins C., Thal L.J., and Bondi M.W. Identification of Alzheimer Disease Risk by Functional Magnetic Resonance Imaging. Arch. Neurol. 62 12 (2005) 1881-1888
24. Garraux G., Salmon E., Degueldre C., Lemaire C., Laureys S., and Franck G. Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal demential. NeuroImage 10 2 (1999) 149-162
25. Good C.D., Johnsrude I.S., Ashburner J., Henson R.N., Friston K.J., and Frackowiak R.S. A voxel-based morphometric study of ageing in 465 normal adult human brains. NeuroImage 14 1 Pt 1 (2001) 21-36
26. Good C.D., Scahill R.I., Fox N.C., Ashburner J., Friston K.J., Chan D., Crum W.R., Rossor M.N., and Frackowiak R.S. Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias. NeuroImage 17 1 (2002) 29-46
27. Grady C.L., Haxby J.V., Horwitz B., Gillette J., Salerno J.A., Gonzalez-Aviles A., Carson R.E., Herscovitch P., Schapiro M.B., and Rapoport S.I. Activation of cerebral blood flow during a visuoperceptual task in patients with Alzheimer-type dementia. Neurobiol. Aging 14 1 (1993) 35-44
28. Grady C.L., McIntosh A.R., Beig S., Keightley M.L., Burian H., and Black S.E. Evidence from functional neuroimaging of a compensatory prefrontal network in Alzheimer's disease. J. Neurosci. 23 3 (2003) 986-993
29. Haier R.J. Cerebral glucose metabolism and intelligence. In: Vernon P. (Ed). Biological Approaches to the Study of Human Intelligence (1993), Ablex, Norwood, NJ 317-332
30. Haier R.J., Siegel B.V., Nuechterlein K.H., Hazlett E., Wu J.C., Paek J., Browning H.L., and Buchsbaum M.S. Cortical Glucose Metabolic-Rate Correlates of Abstract Reasoning and Attention Studied with Positron Emission Tomography. Intelligence 12 2 (1988) 199-217
31. Haier R.J., Siegel B., Tang C., Abel L., and Buchsbaum M.S. Intelligence and Changes in Regional Cerebral Glucose Metabolic-Rate Following Learning. Intelligence 16 3-4 (1992) 415-426
32. Haier R.J., Chueh D., Touchette P., Lott I., et al. Brain size and cerebral glucose metabolic rate in nonspecific mental retardation and Down syndrome. Intelligence 20 2 (1995) 191-210
33. Haier R.J., Hazen K., Fallon J., Alkire M.T., and Lott I. Brain Imaging and classification of mental retardation. In: McIlvane S. (Ed). Perspectives on Fundamental Processes in Intellectual Functioning (1998), Ablex Press, Stamford, CT 115-130
34. Haier R.J., Alkire M.T., White N.S., Uncapher M.R., Head E., Lott I.T., and Cotman C.W. Temporal cortex hypermetabolism in Down syndrome prior to the onset of dementia. Neurology 61 12 (2003) 1673-1679
35. Head E., Lott I.T., Hof P.R., Bouras C., Su J.H., Kim R., Haier R., and Cotman C.W. Parallel compensatory and pathological events associated with Tau pathology in middle aged individuals with Down Syndrome. J. Neuropathol. Exp. Neurol. 62 9 (2003) 917-926
36. Head E., Lott I.T., Patterson D., Doran E., and Haier R.J. Possible compensatory events in adult Down syndrome brain prior to the development of Alzheimer disease neuropathology: Targets for non-pharmacological intervention. J. Alzheimer's Dis. 11 1 (2007) 61-76
37. Herholz K., Nordberg A., Salmon E., Perani D., Kessler J., Mielke R., Halber M., Jelic V., Almkvist O., Collette F., Alberoni M., Kennedy A., Hasselbalch S., Fazio F., and Heiss W.D. Impairment of neocortical metabolism predicts progression in Alzheimer's disease. Dementia Geriatr. Cognit. Disord. 10 6 (1999) 494-504
38. Hirata Y., Matsuda H., Nemoto K., Ohnishi T., Hirao K., Yamashita F., Asada T., Iwabuchi S., and Samejima H. Voxel-based morphometry to discriminate early Alzheimer's disease from controls. Neurosci. Lett. 382 0304-3940 (2005) 269-274
39. Hirata Y., Matsuda H., Nemoto K., Ohnishi T., Hirao K., Yamashita F., Asada T., Iwabuchi S., and Samejima H. Voxel-based morphometry to discriminate early Alzheimer's disease from controls. Neurosci. Lett. 382 3 (2005) 269
40. Jagust W.J., Haan M.N., Eberling J.L., Wolfe N., and Reed B.R. Functional imaging predicts cognitive decline in Alzheimer's disease. J. Neuroimaging 6 3 (1996) 156-160
41. Karas G.B., Burton E.J., Rombouts S., van Schijndel R.A., O'Brien J.T., Scheltens P., McKeith I.G., Williams D., Ballard C., and Barkhof F. A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry. NeuroImage 18 4 (2003) 895-907
42. Karas G.B., Scheltens P., Rombouts S.A.R.B., Visser P.J., van Schijndel R.A., Fox N.C., and Barkhof F. Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. NeuroImage 23 2 (2004) 708
43. Klunk W.E., Engler H., Nordberg A., Bacskai B.J., Wang Y.M., Price J.C., Bergstrom M., Hyman B.T., Langstrom B., and Mathis C.A. Imaging the pathology of Alzheimer's disease: amyloid-imaging with positron emission tomography. Neuromag. Clin. N. Am. 13 4 (2003) 781
44. Lott I.T., and Head E. Down syndrome and Alzheimer's disease: a link between development and aging. Ment. Retard. Dev. Disabil. Res. Rev. 7 3 (2001) 172-178
45. Minoshima S., Giordani B., Berent S., Frey K.A., Foster N.L., and Kuhl D.E. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann. Neurol. 42 1 (1997) 85-94
46. Minoshima S., Cross D.J., Foster N.L., Henry T.R., and Kuhl D.E. Discordance between traditional pathologic and energy metabolic changes in very early Alzheimer's disease. Pathophysiological implications. Ann. N. Y. Acad. Sci. 893 (1999) 350-352
47. Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging 32 4 (2005) 486
48. Mosconi L., Perani D., Sorbi S., Herholz K., Nacmias B., Holthoff V., Salmon E., Baron J.C., De Cristofaro M.T.R., Padovani A., Borroni B., Franceschi M., Bracco L., and Pupi A. MCI conversion to dementia and the APOE genotype-a prediction study with FDG-PET. Neurology 63 12 (2004) 2332-2340
49. Mosconi L., Pupi A., De Cristofaro M.T., Fayyaz M., Sorbi S., and Herholz K. Functional interactions of the entorhinal cortex: an 18F-FDG PET study on normal aging and Alzheimer's disease. J. Nucl. Med. 45 3 (2004) 382-392
50. Mosconi L., Tsui W.H., De Santi S., Li J., Rusinek H., Convit A., Li Y., Boppana M., and de Leon M.J. Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology 64 11 (2005) 1860-1867
51. Mungas D., Harvey D., Reed B.R., Jagust W.J., DeCarli C., Beckett L., Mack W.J., Kramer J.H., Weiner M.W., Schuff N., and Chui H.C. Longitudinal volumetric MRI change and rate of cognitive decline. Neurology 65 4 (2005) 565-571
52. Oliver C., and Holland A.J. Down's syndrome and Alzheimer's disease: a review. Psychol. Med. 16 2 (1986) 307-322
53. Pearlson G.D., Breiter S.N., Aylward E.H., Warren A.C., Grygorcewicz M., Frangou S., Barta P.E., and Pulsifer M.B. MRI brain changes in subjects with Down syndrome with and without dementia. Dev. Med. Child Neurol. 40 5 (1998) 326-334
54. Perez S.E., Lazarov O., Koprich J.B., Chen E.-Y., Rodriguez-Menendez V., Lipton J.W., Sisodia S.S., and Mufson E.J. Nigrostriatal dysfunction in familial Alzheimer's disease-linked APPswe/PS1{Delta}E9 transgenic mice. J. Neurosci. 25 44 (2005) 10220-10229
55. Pietrini P., Dani A., Furey M.L., Alexander G.E., Freo U., Grady C.L., Mentis M.J., Mangot D., Simon E.W., Horwitz B., Haxby J.V., and Schapiro M.B. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia. Am. J. Psychiatry 154 8 (1997) 1063-1069
56. Prasher V., Cumella S., Natarajan K., Rolfe E., Shah S., and Haque M.S. Magnetic resonance imaging, Down's syndrome and Alzheimer's disease: research and clinical implications. J. Intellect. Disabil. Res. 47 part 2 (2003) 90-100
57. Raz N., Torres I.J., Briggs S.D., Spencer W.D., Thornton A.E., Loken W.J., Gunning F.M., McQuain J.D., Driesen N.R., and Acker J.D. Selective neuroanatomic abnormalities in Down's syndrome and their cognitive correlates: evidence from MRI morphometry. Neurology 45 2 (1995) 356-366
58. Reiman E.M., Chen K.W., Alexander G.E., Caselli R.J., Bandy D., Osborne D., Saunders A.M., and Hardy J. Correlations between apolipoprotein E epsilon 4 gene dose and brain-imaging measurements of regional hypometabolism. Proc. Natl. Acad. Sci. U. S. A. 102 23 (2005) 8299-8302
59. Salmon E., Lespagnard S., Marique P., Peeters F., Herholz K., Perani D., Holthoff V., Kalbe E., Anchisi D., Adam S., Collette F., and Garraux G. Cerebral metabolic correlates of four dementia scales in Alzheimer's disease. J. Neurol. 252 3 (2005) 283
60. Schapiro M.B., Ball M.J., Grady C.L., Haxby J.V., Kaye J.A., and Rapoport S.I. Dementia in Down's syndrome: cerebral glucose utilization, neuropsychological assessment, and neuropathology. Neurology 38 6 (1988) 938-942
61. Shiino A., Watanabe T., Maeda K., Kotani E., Akiguchi I., and Matsuda M. Four subgroups of Alzheimer's disease based on patterns of atrophy using VBM and a unique pattern for early onset disease. NeuroImage 33 1 (2006) 17
62. Shoghi-Jadid K., Small G.W., Agdeppa E.D., Kepe V., Ercoli L.M., Siddarth P., Read S., Satyamurthy N., Petric A., Huang S.C., and Barrio J.R. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am. J. Geriatr. Psychiatry 10 1 (2002) 24-35
63. Shultz J., Aman M., Kelbley T., Wallace C.L., Burt D.B., Primeaux-Hart S., Loveland K., Thorpe L., Bogos E.S., Timon J., Patti P., and Tsiouris J. Evaluation of screening tools for dementia in older adults with mental retardation. Am. J. Ment. Retard. 109 2 (2004) 98-110
64. Silverman D.H., Small G.W., Chang C.Y., Lu C.S., Kung De Aburto M.A., Chen W., Czernin J., Rapoport S.I., Pietrini P., Alexander G.E., Schapiro M.B., Jagust W.J., Hoffman J.M., Welsh-Bohmer K.A., Alavi A., Clark C.M., Salmon E., de Leon M.J., Mielke R., Cummings J.L., Kowell A.P., Gambhir S.S., Hoh C.K., and Phelps M.E. Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA 286 17 (2001) 2120-2127
65. Silverman W., Schupf N., Zigman W., Devenny D., Miezejeski C., Schubert R., and Ryan R. Dementia in adults with mental retardation: assessment at a single point in time. Am. J. Ment. Retard. 109 2 (2004) 111
66. Talairach, J., Tournoux, P., 1988. Co-planar Stereotaxic Atlas of the Human Brain: A 3-Dimensional Proportional System, An Approach to Cerebral Imaging. Stuttgart: G. Thieme, Thieme Medical Publishers.
67. Teipel S.J., and Hampel H. Neuroanatomy of Down syndrome in vivo: a model of preclinical Alzheimer's disease. Behav. Genet. 36 3 (2006) 405-415
68. Teipel S.J., Alexander G.E., Schapiro M.B., Moller H.J., Rapoport S.I., and Hampel H. Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry. Brain 25 (2004) 25
69. Teipel S., Pruessner J., Faltraco F., Born C., Rocha-Unold M., Evans A., Moller H.J., and Hampel H. Comprehensive dissection of the medial temporal lobe in AD: measurement of hippocampus, amygdala, entorhinal, perirhinal and parahippocampal cortices using MRI. J. Neurol. 253 6 (2006) 794-800
70. Tekin S., and Cummings J.L. Frontal-subcortical neuronal circuits and clinical neuropsychiatry-an update. J. Psychosom. Res. 53 2 (2002) 647-654
71. Thompson P.M., Hayashi K.M., de Zubicaray G., Janke A.L., Rose S.E., Semple J., Herman D., Hong M.S., Dittmer S.S., Doddrell D.M., Toga A.W., Sowell E.R., Peterson B.S., Welcome S.E., and Henkenius A.L. Dynamics of gray matter loss in Alzheimer's disease: mapping cortical change across the human life span. J. Neurosci. 23 3 (2003) 994-1005
72. White N.B., Alkire M.T., and Haier R.J. A voxel-based morphometric study of non-demented adults with Down syndrome. NeuroImage 20 1 (2003) 393-403
73. Wisniewski K.E., Dalton A.J., McLachlan C., Wen G.Y., and Wisniewski H.M. Alzheimer's disease in Down's syndrome: clinicopathologic studies. Neurology 35 7 (1985) 957-961